Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epigen is a line of topical dermatological products developed by Resilient Cosmeceuticals, designed to address a variety of skin conditions including xerosis, diabetic skin, atopic dermatitis, and pregnancy-related stretch marks. The product range includes Epigen Cream, Epigen Aqua Moisturizing Lotion, and Epigen 5.5 Bar (a syndet bar). These formulations function primarily as emollients and humectants, working to restore the skin's natural moisture barrier and provide hydration. Epigen Cream is specifically indicated for dry and diabetic skin, as well as sore nipples and stretch marks, while Epigen Aqua is used for photo-damaged skin and post-procedural recovery following laser treatments or dermabrasion. The products are approved and marketed in India for both therapeutic and general skin care purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Epigen.